Dancing with “Death”: P-Methoxyamphetamine Overdose and Its Acute Management

References

• Martin TL. Three cases of fatal paramethoxyamphetamine overdose. J Anal Toxicol 2001; 25(7)649–651
   PubMed Web of Science ®Google Scholar
• Kalant H. The pharmacology and toxicology of “Ecstasy” (MDMA) and related drugs. CMAJ 2001; 165(7)917–928
   PubMed Web of Science ®Google Scholar
• Green AR, Cross AJ, Goodwin GM. Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or “Ecstasy”). Psychopharmacology (Berl) 1995; 119(3)247–260
   PubMed Web of Science ®Google Scholar
• Green AL, El Hait MA. P-Methoxyamphetamine, a potent reversible inhibitor of Type-A monoamine oxidase in vitro and in vivo. J Pharm Pharmacol 1980; 32(4)262–266
   PubMed Web of Science ®Google Scholar
• Wu D, Otton SV, Inaba T, Kalow W, Sellers EM. Interactions of amphetamine analogs with human liver CYP2D6. Biochem Pharmacol 1997; 53(11)1605–1612
   PubMed Web of Science ®Google Scholar
• Bach MV, Coutts RT, Baker GB. Involvement of CYP2D6 in the in vitro metabolism of amphetamine two n-alkylamphetamines and their 4-methoxylated derivatives. Xenobiotica 1999; 29(7)719–732
   PubMed Web of Science ®Google Scholar
• Kaminskas LM, Irvine RJ, Callaghan PD, White JM, Kirkbride P. The contribution of the metabolite p-hydroxyamphetamine to the central actions of p-methoxyamphetamine. Psychopharmacology (Berl) 2002; 160(2)155–160
   PubMed Web of Science ®Google Scholar
• Tucker GT, Lennard MS, Ellis SW, Woods HF, Cho AK, Lin LY, Hiratsuka A, Schmitz DA, Chu TY. The demethylenation of methylenedioxymethamphetamine (“Ecstasy”) by debrisoquine hydroxylase (CYP2D6). Biochem Pharmacol 1994; 47(7)1151–1156
   PubMed Web of Science ®Google Scholar
• Kraner JC, McCoy DJ, Evans MA, Evans LE, Sweeney BJ. Fatalities caused by the MDMA-related drug paramethoxyamphetamine (PMA). J Anal Toxicol 2001; 25(7)645–648
   PubMed Web of Science ®Google Scholar
• Maurer HH, Bickeboeller-Friedrich J, Kraemer T, Peters FT. Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs (‘Ecstasy’). Toxicol Lett 2000; 112–113: 133–142
   PubMed Web of Science ®Google Scholar
• Kreth K, Kovar K, Schwab M, Zanger UM. Identification of the human cytochromes P450 involved in the oxidative metabolism of “Ecstasy”-related designer drugs. Biochem Pharmacol 2000; 59(12)1563–1571
   PubMed Web of Science ®Google Scholar
• Shulgin A, Shulgin A. PIHKAL; A Chemical Love Story. Transform Press, Berkeley, USA 1991
   Google Scholar
• Baselt RC. Disposition of toxic drugs and chemicals in man. 5th ed, Chemical Toxicology Institute, Foster City, California 2000
   Google Scholar
• Felgate HE, Felgate PD, James RA, Sims DN, Vozzo DC. Recent paramethoxyamphetamine deaths. J Anal Toxicol 1998; 22(2)169–172
   PubMed Web of Science ®Google Scholar
• Cimbura G. PMA deaths in ontario. Can Med Assoc J 1974; 110(11)1263–1267
   PubMed Web of Science ®Google Scholar
• Katagi M, Tsuchihashi H. Update on clandestine amphetamines and their analogues recently seen in Japan. J Health Sci 2002; 48(1)14–21
   Web of Science ®Google Scholar
• Glennon RA, Young R, Dukat M, Cheng Y. Initial characterization of PMMA as a discriminative stimulus. Pharmacol Biochem Behav 1997; 57(1–2)151–158
   PubMed Web of Science ®Google Scholar
• , Longo M, Humeniuk R, Christie P, Topp L, Ali R. SA Party Drugs Trends 2001. Findings from the Illicit Drugs Reporting System, Party Drugs Module. Report No.: Technical Report No. 131. University of New South Wales: National Drug and Alcohol Research Council; 2002.
   Google Scholar
• , Dillon, P. PMA—How Dangerous Was It? 2002.
   Google Scholar
• Byard RW, James RA, Gilbert JD, Felgate PD. Another PMA-related fatality in adelaide. Med J Aust 1999; 170(3)139–140
   PubMed Web of Science ®Google Scholar
• Kirkbride KP, Ward AD, Jenkins NF, Klass G, Coumbaros JC. Synthesis of 4-methyl-5-arylpyrimidines and 4-arylpyrimidines: route specific markers for the leuckardt preparation of amphetamine 4-methoxyamphetamine, and 4-methylthioamphetamine. Forensic Sci Int 2001; 115(1–2)53–67
   PubMed Web of Science ®Google Scholar
• , Hansson R. Letter to Kirkbride, K. P.
   Google Scholar
• Dal Cason TA. A re-examination of the mono-methoxy positional ring isomers of amphetamine, methamphetamine and phenyl-2-propanone. Forensic Sci Int 2001; 119(2)168–194
   PubMed Web of Science ®Google Scholar
• Coumbaros JC, Kirkbride KP, Klass G. Application of solid-phase microextraction to the profiling of an illicit drug: manufacturing impurities in illicit 4-methoxyamphetamine. J Forensic Sci 1999; 44(6)1237–1242
   PubMed Web of Science ®Google Scholar
• Hegadoren KM, Martin-Iverson MT, Baker GB. Comparative behavioural and neurochemical studies with a psychomotor stimulant, an hallucinogen and 3,4-methylenedioxy analogues of amphetamine. Psychopharmacology (Berl) 1995; 118(3)295–304
   PubMed Web of Science ®Google Scholar
• Matthews RT, Champney TH, Frye GD. Effects of (±)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats. Pharmacol Biochem Behav 1989; 33(4)741–747
   PubMed Web of Science ®Google Scholar
• Spanos LJ, Yamamoto BK. Acute and subchronic effects of methylenedioxymethamphetamine [(+/−)MDMA] on locomotion and serotonin syndrome behavior in the rat. Pharmacol Biochem Behav 1989; 32(4)835–840
   PubMed Web of Science ®Google Scholar
• Daws LC, Irvine RJ, Callaghan PD, Toop NP, White JM, Bochner F. Differential behavioural and neurochemical effects of para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine in the rat. Prog Neuropsychopharmacol Biol Psychiatry 2000; 24(6)955–977
   PubMed Web of Science ®Google Scholar
• Westberg, L. Synthetic drug alert: EMCDDA warns national networks. Report No.: 25, Portugal; 2000. DrugNet Europe; http://www.ceis.it/focalpoint/Inglese/download/DrugNet25.pdf.
   Google Scholar
• Brown C, Osterloh J. Multiple severe complications from recreational ingestion of MDMA (‘Ecstasy’). J Am Med Assoc 1987; 258(6)780–781
   Web of Science ®Google Scholar
• Hughes JC, McCabe M, Evans RJ. Intracranial haemorrhage associated with ingestion of ‘Ecstasy’. Arch Emerg Med 1993; 10(4)372–374
   PubMedGoogle Scholar
• Manchanda S, Connolly MJ. Cerebral infarction in association with ecstasy abuse. Postgrad Med J 1993; 69(817)874–875
   PubMed Web of Science ®Google Scholar
• Chadwick IS, Curry PD, Linsley A, Freemont AJ, Doran B. Ecstasy, 3-4 methylenedioxymethamphetamine (MDMA), a fatality associated with coagulopathy and hyperthermia. J R Soc Med 1991; 84(6)371
   PubMed Web of Science ®Google Scholar
• Dowling GP, McDonough ET, III, Bost RO. ‘Eve’ and ‘Ecstasy’ A report of five deaths associated with the use of MDEA and MDMA. J Am Med Assoc 1987; 257(12)1615–1617
   PubMed Web of Science ®Google Scholar
• Campkin NT, Davies UM. Another death from ecstacy. J R Soc Med 1992; 85(1)61
   PubMed Web of Science ®Google Scholar
• Suarez RV, Riemersma R. “Ecstasy” and sudden cardiac death. Am J Forensic Med Pathol 1988; 9(4)339–341
   PubMed Web of Science ®Google Scholar
• Screaton GR, Singer M, Cairns HS, Thrasher A, Sarner M, Cohen SL. Hyperpyrexia and rhabdomyolysis after MDMA (“Ecstasy”) abuse. Lancet 1992; 339(8794)677–678
   PubMed Web of Science ®Google Scholar
• Ling LH, Marchant C, Buckley NA, Prior M, Irvine RJ. Poisoning with the recreational drug paramethoxyamphetamine (“Death”). Med J Aust 2001; 174(9)453–455
   PubMed Web of Science ®Google Scholar
• The Hallucinogen PMA; Dancing With Death. US Department of Justice; 2000 (Drug Intelligence Brief); http://www.usdoj.gov/dea/pubs/intel/20025intellbrief.pdf.
   Google Scholar
• Voorspoels S, Coucke V, Schepens P. Paramethoxyamphetamine: first fatalities in belgium. TIAFT Bull 2001; 31(4)12–13
   Google Scholar
• Lora-Tamayo C, Tena T, Rodriguez A. Amphetamine derivative related deaths. Forensic Sci Int 1997; 85(2)149–157
   PubMed Web of Science ®Google Scholar
• Lechowicz W, Chudzikiewicz E, Janowska E, Stanaszek R. Complex intoxication with p-methoxyamphetamine (PMA) and other phenylalkylamines. Z. Zagadnien Nauk Sadowych 2001; XLVIII: 118–126
   Google Scholar
• , Stimpfl T, Friedrich E, Vycudilik W. Fatal Intoxication with paramethoxyamphetamine (PMA) and paramethoxymetamphetamine (PMMA). TIAFT Conference Proceedings, 39th Annual International Meeting, August 26–30, Prague, Czech Republic, 2001.
   Google Scholar
• , Römhild W, Quednow B, Rosner P. Lethal PMA (p-methoxyamphetamine) and PMMA (p-methoxymetamphetamine) intoxication,). TIAFT Conference Proceedings, 39th Annual International Meeting, August 26–30, Prague, Czech Republic, 2001.
   Google Scholar
• Byard RW, Gilbert J, James R, Lokan RJ. Amphetamine derivative fatalities in south australia-is “Ecstasy” the Culprit?. Am J Forensic Med Pathol 1998; 19(3)261–265
   PubMed Web of Science ®Google Scholar
• James RA, Dinan A. Hyperpyrexia associated with fatal paramethoxyamphetamine (PMA) abuse. Med Sci Law 1998; 38(1)83–85
   PubMed Web of Science ®Google Scholar
• Byard RW, Rodger N, James RA, Kostakis C, Camilleri A. Death and paramethoxyamphetamine-an evolving problem. Med J Aust 2002; 176: 496
   PubMed Web of Science ®Google Scholar
• , Hamilton W. Personal communication to Kirkbride, K. P., 2002.
   Google Scholar
• , Prolov T. Personal communication to Kirkbride, K. P., 2002
   Google Scholar
• Denborough MA, Hopkinson KC. Dantrolene and “Ecstasy”. Med J Aust 1997; 166(3)165–166
   PubMed Web of Science ®Google Scholar
• Mechan AO, Esteban B, O'Shea E, Elliott JM, Colado MI, Green AR. The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, ‘Ecstasy’) to rats. Br J Pharmacol 2002; 135(1)170–180
   PubMed Web of Science ®Google Scholar
• Logan AS, Stickle B, O'Keefe N, Hewitson H. Survival following ‘Ecstasy’ ingestion with a peak temperature of 42 degrees C. Anaesthesia 1993; 48(11)1017–1018
   PubMed Web of Science ®Google Scholar
• Hall AP, Lyburn ID, Spears FD, Riley B. An unusual case of ecstasy poisoning. Intensive Care Med 1996; 22(7)670–671
   PubMed Web of Science ®Google Scholar
• Position statement. J Toxicol Clin Toxicol 1997; 35: 699–762
   PubMed Web of Science ®Google Scholar